168 related articles for article (PubMed ID: 35492313)
21. 18F-FDG PET/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis.
Morita Y; Kuwagata S; Kato N; Tsujimura Y; Mizutani H; Suehiro M; Isono M
Intern Med; 2012; 51(12):1613-8. PubMed ID: 22728501
[TBL] [Abstract][Full Text] [Related]
22. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.
Tateyama M; Fujihara K; Misu T; Arai A; Kaneta T; Aoki M
BMJ Open; 2015 Jan; 5(1):e006763. PubMed ID: 25582454
[TBL] [Abstract][Full Text] [Related]
23. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
25. Semi-quantitative analysis of
Ravikanth R; Singh JK
World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
[No Abstract] [Full Text] [Related]
26. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
27. Polymyositis and dermatomyositis - challenges in diagnosis and management.
Yang SH; Chang C; Lian ZX
J Transl Autoimmun; 2019 Dec; 2():100018. PubMed ID: 32743506
[TBL] [Abstract][Full Text] [Related]
28. (18)F-FDG PET Demonstration of Cancer Recurrence Presenting as Dermatomyositis in a Rare Case of Primary Pleural Lymphoma.
Lee SM; Kim YK; Lee JJ; Lee JW; Lee YJ; Kim HR; Choe G; Kim SE
Nucl Med Mol Imaging; 2011 Mar; 45(1):79-82. PubMed ID: 24899983
[TBL] [Abstract][Full Text] [Related]
29. Value of
Li X; Tan H
Heliyon; 2020 Apr; 6(4):e03707. PubMed ID: 32274435
[TBL] [Abstract][Full Text] [Related]
30. A retrospective cohort study in Chinese patients with adult polymyositis and dermatomyositis: risk of comorbidities and subclassification using machine learning.
Zhu J; Wu L; Zhou Y; Wang R; Chen S; Zhao J; Yu S; Zheng S; Xiao F; Ren H; Yang M; Li J
Clin Exp Rheumatol; 2022 Feb; 40(2):224-236. PubMed ID: 34251311
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-35 in idiopathic inflammatory myopathies.
Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L
Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920
[TBL] [Abstract][Full Text] [Related]
32. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
Flechsig P; Kratochwil C; Schwartz LH; Rath D; Moltz J; Antoch G; Heussel CP; Rieser M; Warth A; Zabeck H; Kauczor HU; Haberkorn U; Giesel FL
J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
[TBL] [Abstract][Full Text] [Related]
33. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
[TBL] [Abstract][Full Text] [Related]
34. Role of
Malik D; Sood A; Mittal BR; Basher RK; Bhattacharya A; Singh G
World J Nucl Med; 2019; 18(2):176-182. PubMed ID: 31040750
[TBL] [Abstract][Full Text] [Related]
35. Current diagnosis and treatment of polymyositis and dermatomyositis.
Sasaki H; Kohsaka H
Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis.
Martis N; Viau P; Zenone T; Andry F; Grados A; Ebbo M; Castela E; Brihaye B; Denis E; Liguori S; Audemard A; Schoindre Y; Morin AS; Terrier B; Marcq L; Mounier N; Lidove O; Chaborel JP; Quinsat D
Eur Radiol; 2019 Dec; 29(12):6708-6716. PubMed ID: 31250167
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies in Myositis. How to Achieve a Comprehensive Strategy for Serological Testing.
Mende M; Borchardt-Lohölter V; Meyer W; Scheper T; Schlumberger W
Mediterr J Rheumatol; 2019 Sep; 30(3):155-161. PubMed ID: 32185358
[TBL] [Abstract][Full Text] [Related]
38. Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis.
Lee JH; Lee GY; Kim SJ; Kim KH; Jeon ES; Lee KH; Kim BT; Choi JY
Nucl Med Mol Imaging; 2015 Sep; 49(3):182-90. PubMed ID: 26279691
[TBL] [Abstract][Full Text] [Related]
39. Increased incidence of interstitial pneumonia detected on [
Setti L; Bonacina M; Meroni R; Kirienko M; Galli F; Dalto SC; Erba PA; Bombardieri E
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):777-785. PubMed ID: 32909090
[TBL] [Abstract][Full Text] [Related]
40. Utility of
Amat J; Chanchou M; Olagne L; Descamps L; Flaus A; Bouvet C; Barres B; Valla C; Molnar I; Cougoul A; Mathieu S; Aumaitre O; Soubrier M; Kelly A; Merlin C; Cachin F
Front Med (Lausanne); 2020; 7():394. PubMed ID: 32923444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
